CD44 and non-small cell lung carcinoma: High expression of CD44 is not only associated with the occurrence and migration of NSCLC (Li et al., 2016; Liu et al., 2015), but also with drug resistance and poor prognosis (Liu et al., 2013; Shinohara et al., 2016).